These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 31093097)

  • 1. Reporting of adverse reactions to benznidazole: does medical expertise matter?
    Pereiro AC; Lenardón M; Zeballos A; Chopita M; Abril M; Gold S
    Rev Panam Salud Publica; 2018; 42():e69. PubMed ID: 31093097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study.
    Hasslocher-Moreno AM; Saraiva RM; Sangenis LHC; Xavier SS; de Sousa AS; Costa AR; de Holanda MT; Veloso HH; Mendes FSNS; Costa FAC; Boia MN; Brasil PEAA; Carneiro FM; da Silva GMS; Mediano MFF
    EClinicalMedicine; 2021 Jan; 31():100694. PubMed ID: 33554085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease.
    Olivera MJ; Cucunubá ZM; Valencia-Hernández CA; Herazo R; Agreda-Rudenko D; Flórez C; Duque S; Nicholls RS
    PLoS One; 2017; 12(9):e0185033. PubMed ID: 28949997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte Transformation Test (LTT) in Allergy to Benznidazole: A Promising Approach.
    Marques-Mejías MA; Cabañas R; Ramírez E; Domínguez-Ortega J; Fiandor A; Trigo E; Quirce S; Bellón T
    Front Pharmacol; 2019; 10():469. PubMed ID: 31164819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.
    Figueiras A; Herdeiro MT; Polónia J; Gestal-Otero JJ
    JAMA; 2006 Sep; 296(9):1086-93. PubMed ID: 16954488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pharmacological profile of benznidazole for treatment of Chagas disease.
    Kratz JM; Garcia Bournissen F; Forsyth CJ; Sosa-Estani S
    Expert Rev Clin Pharmacol; 2018 Oct; 11(10):943-957. PubMed ID: 30111183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia.
    Alonso-Vega C; Urbina JA; Sanz S; Pinazo MJ; Pinto JJ; Gonzalez VR; Rojas G; Ortiz L; Garcia W; Lozano D; Soy D; Maldonado RA; Nagarkatti R; Debrabant A; Schijman A; Thomas MC; López MC; Michael K; Ribeiro I; Gascon J; Torrico F; Almeida IC
    BMJ Open; 2021 Dec; 11(12):e052897. PubMed ID: 34972765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
    Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
    Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoencapsulation of benznidazole in calcium carbonate increases its selectivity to Trypanosoma cruzi.
    Tessarolo LD; de Menezes RRPPB; Mello CP; Lima DB; Magalhães EP; Bezerra EM; Sales FAM; Barroso Neto IL; Oliveira MF; Dos Santos RP; Albuquerque EL; Freire VN; Martins AM
    Parasitology; 2018 Aug; 145(9):1191-1198. PubMed ID: 29642963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
    Tandon VR; Mahajan V; Khajuria V; Gillani Z
    Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study.
    Jacobs TG; Hilda Ampadu H; Hoekman J; Dodoo ANO; Mantel-Teeuwisse AK
    BMC Public Health; 2018 Dec; 18(1):1384. PubMed ID: 30563498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.
    Herdeiro MT; Figueiras A; Polónia J; Gestal-Otero JJ
    Drug Saf; 2005; 28(9):825-33. PubMed ID: 16119975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting.
    Alhawassi TM; Krass I; Bajorek BV; Pont LG
    Clin Interv Aging; 2014; 9():2079-86. PubMed ID: 25489239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.
    Bond CA; Raehl CL
    Pharmacotherapy; 2006 Jun; 26(6):735-47. PubMed ID: 16716127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions of non-opioid and opioid analgesics reported to Croatian national authority from 2007 to 2014.
    Sunara P; Krnic D; Puljak L
    Acta Med Acad; 2017 Nov; 46(2):94-104. PubMed ID: 29338273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to different benznidazole doses in animal models of chronic phase Chagas disease: a critical review.
    Scarim CB; Ribeiro AR; Rosa JAD; Chin CM
    Rev Soc Bras Med Trop; 2018; 51(2):133-140. PubMed ID: 29768544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texting-Based Reporting of Adverse Drug Reactions to Ensure Patient Safety: A Feasibility Study.
    Vergeire-Dalmacion G; Castillo-Carandang NT; Juban NR; Amarillo ML; Tagle MP; Baja ES
    JMIR Public Health Surveill; 2015; 1(2):e12. PubMed ID: 27227130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.